Eli Lilly and Company, D-Wave Quantum, and Thermo Fisher Scientific are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are publicly traded shares of companies that research, develop, manufacture and market prescription drugs, vaccines and over-the-counter treatments. Their market value depends on factors like clinical trial outcomes, regulatory approvals, patent expirations and competitive pressures. Investors track these stocks for their growth potential as well as the risks inherent in drug development and healthcare regulation. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
LLY stock traded down $3.21 during mid-day trading on Thursday, reaching $762.63. The company had a trading volume of 1,867,052 shares, compared to its average volume of 3,637,775. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.97 and a current ratio of 1.15. The firm has a fifty day simple moving average of $772.75 and a 200 day simple moving average of $799.41. The company has a market capitalization of $722.77 billion, a price-to-earnings ratio of 65.13, a price-to-earnings-growth ratio of 1.40 and a beta of 0.48. Eli Lilly and Company has a fifty-two week low of $677.09 and a fifty-two week high of $972.53.
Read Our Latest Research Report on LLY
D-Wave Quantum (QBTS)
D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.
NYSE QBTS traded down $1.03 during trading on Thursday, reaching $16.79. The company's stock had a trading volume of 49,993,670 shares, compared to its average volume of 44,171,109. The business's fifty day moving average price is $10.16 and its 200-day moving average price is $7.53. D-Wave Quantum has a twelve month low of $0.75 and a twelve month high of $19.77. The firm has a market cap of $4.91 billion, a price-to-earnings ratio of -39.98 and a beta of 1.49.
Read Our Latest Research Report on QBTS
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of Thermo Fisher Scientific stock traded down $4.35 during trading on Thursday, reaching $399.31. The company's stock had a trading volume of 1,395,298 shares, compared to its average volume of 1,894,142. The business has a 50 day moving average price of $424.35 and a 200-day moving average price of $497.38. Thermo Fisher Scientific has a 12-month low of $390.50 and a 12-month high of $627.88. The company has a quick ratio of 1.29, a current ratio of 1.66 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $150.74 billion, a P/E ratio of 24.16, a price-to-earnings-growth ratio of 2.99 and a beta of 0.82.
Read Our Latest Research Report on TMO
Featured Articles
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
